ArticleCancers2019

Paclitaxel-Induced Src Activation Is Inhibited by Dasatinib Treatment, Independently of Cancer Stem Cell Properties, in a Mouse Model of Ovarian Cancer.

Elif Kadife et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.